Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 31, 2025

Effect of Omega-3 Supplementation vs. Placebo on Blood Lipid Levels in Patients with Ischemic Heart Disease: A Systematic Review and Meta-Analysis

View Full Paper
Ask AI
Bookmark
Share

Authors

ANAhmed NegmAAAhmed M. AshourMMMazin Mohamed

Discussion

Loading...

Member takes

Overview

Systematic review shows omega-3 significantly reduces triglycerides and LDL-C in patients with ischemic heart disease, suggesting potential as adjunct therapy.

Key Points

  • Omega-3 supplementation effectively reduces triglycerides by 17.53 mg/dL in patients with ischemic heart disease.
  • LDL-C levels decreased by 9.43 mg/dL after omega-3 supplementation, indicating a positive effect on lipid profiles.
  • Data was derived from 10 randomized controlled trials involving 633 patients with established criteria for ischemic heart disease.
  • Finding supports omega-3 as a potential treatment for managing dyslipidemia in ischemic heart disease, emphasizing the need for further research.

Cite This Study

Negm et al. (2025) studied this question.

synapsesocial.com/papers/689a094be6551bb0af8cf3a1https://doi.org/10.21203/rs.3.rs-6408149/v1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Omega-3 supplementation and cardiometabolic risk factors in obese/overweight children and adolescents: a GRADE assessed systematic review and meta-analysis2025
  2. 2Mendelian Randomization Indicates Enhanced Lipid Control is Essential for Omega-3's Cardiovascular Protection2025
  3. 3The effect of omega-3 supplementation on metabolic, inflammatory and oxidative stress biomarkers in pregnant women: a systematic review and meta-analysis2025 · 2 citations
  4. 4POLYUNSATURATED FATTY ACIDS AND THEIR BENEFICIAL EFFECT ONHEART DISEASE: A REVIEW2025
  5. 5Omega-3 Fatty Acids in Cardiovascular Health: Navigating the Duality of Benefits and Risks2025